GB2072504B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB2072504B
GB2072504B GB8010406A GB8010406A GB2072504B GB 2072504 B GB2072504 B GB 2072504B GB 8010406 A GB8010406 A GB 8010406A GB 8010406 A GB8010406 A GB 8010406A GB 2072504 B GB2072504 B GB 2072504B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8010406A
Other versions
GB2072504A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coppen A J
Original Assignee
Coppen A J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coppen A J filed Critical Coppen A J
Priority to GB8010406A priority Critical patent/GB2072504B/en
Publication of GB2072504A publication Critical patent/GB2072504A/en
Application granted granted Critical
Publication of GB2072504B publication Critical patent/GB2072504B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8010406A 1980-03-27 1980-03-27 Pharmaceutical compositions Expired GB2072504B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8010406A GB2072504B (en) 1980-03-27 1980-03-27 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8010406A GB2072504B (en) 1980-03-27 1980-03-27 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
GB2072504A GB2072504A (en) 1981-10-07
GB2072504B true GB2072504B (en) 1983-10-26

Family

ID=10512444

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8010406A Expired GB2072504B (en) 1980-03-27 1980-03-27 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB2072504B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089948B1 (en) * 1981-10-05 1985-08-14 COPPEN, Alec James Pharmaceutical compositions
GB2133285A (en) * 1983-01-12 1984-07-25 Alec James Coppen Pharmaceutical compositions
IT1229517B (en) * 1989-01-31 1991-09-03 Bioresearch Spa USE OF 5-METHYLTETRAHYDROPHOLIC ACID, OF 5 FORMYLTHETRAHYDROPHOLIC ACID, AND OF THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE SUITABLE FOR BEING EMPLOYED IN THE TREATMENT OF DISORDERS IN THE TREATMENT OF DISORDERS.
IT1229203B (en) * 1989-03-22 1991-07-25 Bioresearch Spa USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS.
TW361279U (en) * 1995-01-31 1999-06-11 Wilson Sporting Goods Co Ltd Shaft for a golf club, set of golf clubs and method of selecting shafts
GB2336534A (en) * 1998-04-24 1999-10-27 Alec James Coppen Anti-depressant - Folic Acid Combination
JP2002512965A (en) * 1998-04-24 2002-05-08 スカリスタ リミティッド Treatment of depression and pharmaceutical preparations therefor
FR2816944B1 (en) * 2000-11-17 2005-10-21 Dospharma NOVEL LITHIUM SALTS, PHARMACEUTICAL COMPOSITIONS BASED ON THESE LITHIUM SALTS AND THEIR APPLICATIONS AS A MEDICINAL PRODUCT
EP1319663A1 (en) * 2001-12-17 2003-06-18 Dospharma S.A. Antidepressant folic -, folinic- and glutamic-acid lithium salts
AU2007299726A1 (en) * 2006-09-22 2008-03-27 Braincells, Inc. Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
RU2717343C1 (en) * 2019-03-01 2020-03-23 Евгений Владимирович Плотников Agent possessing cytoprotective action

Also Published As

Publication number Publication date
GB2072504A (en) 1981-10-07

Similar Documents

Publication Publication Date Title
ZA813465B (en) Pharmaceutical composition
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
ZA824622B (en) Pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
ZA825397B (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
ZA822856B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8324133D0 (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
ZA82652B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
DE3377696D1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
IL62432A0 (en) Pharmaceutical compositions based on sulphonamide-potentiator combinations
ZA817684B (en) Pharmaceutical compositions
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
ZA826477B (en) Pharmaceutical compositions
ZW18582A1 (en) Pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
ZA815175B (en) Pharmaceutical composition

Legal Events

Date Code Title Description
727 Application made for amendment of specification (sect. 27/1977)
727A Application for amendment of specification now open to opposition (sect. 27/1977)
727B Case decided by the comptroller ** specification amended (sect. 27/1977)
SP Amendment (slips) printed
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19990327